Ganymed Robotics

Executive Summary

Ganymed Robotics is a French medical technology company founded in 2018, developing an advanced AI and robotics platform for orthopedic surgery, specifically joint replacement procedures. The company's core innovation is a 'robot-with-eyes' system that performs marker-less, contactless registration of patient anatomy, eliminating the need for traditional cutting guides and intramedullary rods. This approach aims to improve surgical accuracy, reduce invasiveness, and enhance efficiency. Currently at the pre-clinical stage, Ganymed is focusing on regulatory validation and preparing for clinical trials. The total addressable market for robotic-assisted orthopedic surgery is large and growing, driven by aging populations and demand for minimally invasive procedures. Ganymed's technology has the potential to differentiate from competitors by simplifying workflow and reducing radiation exposure. With a strong IP portfolio and experienced team, the company is well-positioned in the European medtech landscape. Key challenges include securing funding for clinical studies and achieving regulatory clearance in major markets.

Upcoming Catalysts (preview)

• Q4 2026First-in-Human Clinical Trial Start60% success
• Q3 2026Series B Funding Round Closing70% success
• Q1 2027CE Marking Submission for Orthopedic Platform55% success